Diminished interferon-gamma production and responsiveness after endotoxin administration to healthy humans

J Infect Dis. 2002 Dec 15;186(12):1748-53. doi: 10.1086/345675. Epub 2002 Nov 22.

Abstract

To obtain insight in the capacity of the lipopolysaccharide (LPS)-tolerant host to produce interferon (IFN)-gamma and to respond to this cytokine, whole blood was obtained from healthy humans before and 4 h after intravenous injection of LPS (4 ng/kg) and stimulated ex vivo. LPS exposure in vivo resulted in a diminished capacity to produce IFN-gamma after restimulation with LPS, together with a reduced ability to release the IFN-gamma-inducing cytokines interleukin (IL)-12 and IL-18 and with reduced responsiveness toward these cytokines. In addition, IFN-gamma responsiveness was strongly diminished after in vivo LPS exposure, as shown by the fact that blood obtained after LPS injection could not be primed by IFN-gamma for LPS-induced tumor necrosis factor-alpha release and that peripheral blood monocytes could not be stimulated by IFN-gamma to up-regulate major histocompatibility complex type II expression. Experimentally induced immunoparalysis is associated with strongly reduced IFN-gamma production and responsiveness.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Down-Regulation
  • Histocompatibility Antigens Class II / biosynthesis
  • Humans
  • Immune Tolerance*
  • Injections, Intravenous
  • Interferon-gamma / biosynthesis*
  • Interferon-gamma / pharmacology
  • Interleukin-12 / biosynthesis
  • Interleukin-18 / biosynthesis
  • Lipopolysaccharides / administration & dosage*
  • Male
  • Monocytes / immunology
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Histocompatibility Antigens Class II
  • Interleukin-18
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-12
  • Interferon-gamma